Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort.
Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort.
复制标题
DOI:
10.1002/lt.26187
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Bittermann T
中科院分区:
文献类型:
--
作者:
Wong NZ;Reddy KR;Bittermann T
The impact of acute liver failure (ALF) etiology on waitlist and post-transplant outcomes, independent of severity of illness is incompletely characterized. All adults (N=1,691) listed for primary liver transplantation (LT) between 2002–2019 with ALF due to acetaminophen (APAP), drug-induced liver injury (DILI), autoimmune hepatitis (AIH) and hepatitis B virus (HBV) were identified in the United Network for Organ Sharing database. ALF etiology was evaluated as an independent predictor of waitlist mortality and spontaneous survivorship (SS; versus outcome of LT), as well as post-LT overall survival, graft survival and in-hospital mortality using multivariable models that accounting for differences in clinical parameters at listing. Accounting for severity of illness at listing, waitlist mortality and SS for DILI, AIH and HBV were each lower than for APAP (adjusted relative risk ratio <1 in all analyses with p<0.001 for both outcomes). ALF etiology was not associated with adjusted overall survival post-LT (p=0.09) or graft survival (p=0.1). Inpatient mortality rate post-LT was high at 9%. While ALF etiology was also not associated with adjusted inpatient mortality (p=0.4), cause of death (COD) was different. For example, the rate of post-LT brain death was 5.3% for APAP, 3.0% for other DILI, 1.1% for AIH and 3.0% for HBV (p=0.02). ALF etiology is an independent predictor of waitlist outcome, even after adjusting for severity of illness, but is not associated with post-LT outcomes with the exception of COD. The majority of post-LT deaths for all ALF etiologies studied occurred during the index hospital stay, suggesting a continued need for enhanced prognostic tools to ensure efficient organ utilization, and ALF- and etiology-specific post-LT care to prevent brain death.
登录
查看更多内容
影响因子:
8.8
作者:
Freeman, R. B., Jr.;Steffick, D. E.;Merion, R. M.
通讯作者:
Merion, R. M.
影响因子:
39.2
作者:
Reuben A;Tillman H;Fontana RJ;Davern T;McGuire B;Stravitz RT;Durkalski V;Larson AM;Liou I;Fix O;Schilsky M;McCashland T;Hay JE;Murray N;Shaikh OS;Ganger D;Zaman A;Han SB;Chung RT;Smith A;Brown R;Crippin J;Harrison ME;Koch D;Munoz S;Reddy KR;Rossaro L;Satyanarayana R;Hassanein T;Hanje AJ;Olson J;Subramanian R;Karvellas C;Hameed B;Sherker AH;Robuck P;Lee WM
通讯作者:
Lee WM
影响因子:
6.2
作者:
Barshes, NR;Lee, TC;Goss, JA
通讯作者:
Goss, JA
影响因子:
2.4
作者:
Hey, Penelope;Hanrahan, Timothy P.;Gow, Paul
通讯作者:
Gow, Paul
DOI:
10.1002/lt.24347
发表时间:
2016-04
期刊:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
影响因子:
--
作者:
Reddy KR;Ellerbe C;Schilsky M;Stravitz RT;Fontana RJ;Durkalski V;Lee WM;Acute Liver Failure Study Group
通讯作者:
Acute Liver Failure Study Group